Submission of the Annual Report (AR) requires a comprehensive understanding of the Regulatory framework. One (1) of our leading Italian pharmaceutical development clients approached Freyr with a business imperative to compile, evaluate, and submit an AR to the US FDA.
The client received complete benefit and understanding through Freyr’s Regulatory Affairs and Operations team's support, which included internal reviews and necessary updated documentation support.
Download the proven case now.
Fill the form below to download the Case Study